By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
The macroscopic materialisation of myocardial microstructure and its significance for heart function are essential.
Despite this significance, it is still difficult to characterise cellular properties at the organ level, and a comprehensive description of the heart’s structure is still lacking.
The method of perfusing the isolated heart in vitro has had a significant impact on cardiac function for more than a century.
Large animals like dogs and pigs were frequently used in animal models for acute, subacute, and chronic myocardial infarction.
Recently, rabbits, rats, and mice have also been used as models since they are inexpensive, may be used in many investigations, and are simple to house during the trial.
The Global Rabbit cardiovascular imaging system market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.
With the Quantum GX2 microCT imaging equipment, one can see beyond bone and into cancer, cardiovascular and pulmonary illnesses, and much more.
The Quantum GX2 requires a lot of versatility. The Quantum GX2 microCT imaging system combines high speed, low dose scans—perfect for longitudinal studies—across multiple species (mice, rats, and rabbits) with high resolution ex vivo scanning to give performance and flexibility needed to not only image, but also better understand rabbit disease models.
A complete multispecies preclinical imaging system, the Quantum GX2 microCT scanner has the flexibility to permit both ex vivo sample scanning and longitudinal in vivo imaging.
A complete rabbit can be scanned in vivo using the 163mm imaging bore, and ex vivo samples can be scanned in high resolution using the 18mm FOV.
The Quantum GX2 microCT imaging system offers the greatest degree of versatility and functionality when used in conjunction with PerkinElmer’s 3-dimensional optical imaging systems and automated bone analysis software (AccuCTTM).
The Quantum GX2 is adaptable enough to provide the results required, regardless of the research focus—oncology, cardiovascular disease, orthopaedics, or pulmonary illness.
